Relation of apolipoprotein E phenotype to myocardial infarction and mortality from coronary artery disease.

[1]  C. Rizzi.  Statistical Methods , 2020, Springer Theses.

[2]  M. Nieminen,et al.  Lipoproteins and their genetic variation in subjects with and without angiographically verified coronary artery disease. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[3]  D. Roberts,et al.  The effect of fasting triacylglyceride concentration and apolipoprotein E polymorphism on postprandial lipemia. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[4]  J. Hixson.  Apolipoprotein E polymorphisms affect atherosclerosis in young males. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[5]  H. Gylling,et al.  Serum low density lipoprotein cholesterol level and cholesterol absorption efficiency are influenced by apolipoprotein B and E polymorphism and by the FH-Helsinki mutation of the low density lipoprotein receptor gene in familial hypercholesterolemia. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[6]  Chun-Fang Xu,et al.  Apolipoprotein E polymorphism and plasma lipid, lipoprotein, and apolipoprotein levels in Italian children , 1991, Genetic epidemiology.

[7]  L. Kuller,et al.  A simplified method for screening the apolipoprotein E polymorphism. , 1991, Human heredity.

[8]  E. Meilahn,et al.  Phenotypic effects of apolipoprotein structural variation on lipid profiles. III. Contribution of apolipoprotein E phenotype to prediction of total cholesterol, apolipoprotein B, and low density lipoprotein cholesterol in the healthy women study. , 1990, Arteriosclerosis.

[9]  T. Lehtimäki,et al.  Apolipoprotein E phenotypes in Finnish youths: a cross-sectional and 6-year follow-up study. , 1990, Journal of lipid research.

[10]  J. Huttunen,et al.  Apolipoprotein E4 homozygosity predisposes to serum cholesterol elevation during high fat diet. , 1990, Arteriosclerosis.

[11]  I. Makino,et al.  Increased frequencies of apolipoprotein ε2 and ε4 alleles in patients with ischemic heart disease , 1989 .

[12]  M. Nieminen,et al.  Apoprotein E Polymorphism and Coronary Artery Disease: Increased Prevalence of Apolipoprotein E‐4 in Angiographically Verified Coronary Patients , 1989, Arteriosclerosis.

[13]  Brewer Hb,et al.  The role of apolipoprotein E and lipoprotein receptors in modulating the in vivo metabolism of apolipoprotein B-containing lipoproteins in humans. , 1988 .

[14]  C. Sing,et al.  Apolipoprotein E polymorphism and atherosclerosis. , 1988, Arteriosclerosis.

[15]  M. Weintraub,et al.  Dietary fat clearance in normal subjects is regulated by genetic variation in apolipoprotein E. , 1987, The Journal of clinical investigation.

[16]  L. Kuller,et al.  Usefulness of sex steroid hormone levels in predicting coronary artery disease in men. , 1987, The American journal of cardiology.

[17]  D. Steinberg,et al.  Lipoproteins and the pathogenesis of atherosclerosis. , 1987, Circulation.

[18]  C. Sing,et al.  Apolipoprotein E polymorphism and plasma cholesterol response to probucol. , 1987, Metabolism: clinical and experimental.

[19]  P. Wilson,et al.  Apolipoprotein E isoform phenotyping methodology and population frequency with identification of apoE1 and apoE5 isoforms. , 1987, Journal of lipid research.

[20]  A. G. Duchene,et al.  Quality control of biochemical data in the Multiple Risk Factor Intervention Trial: Central Laboratory. , 1986, Controlled clinical trials.

[21]  R. Gregg,et al.  Abnormal in vivo metabolism of apolipoprotein E4 in humans. , 1986, The Journal of clinical investigation.

[22]  J. Ockene.  Coronary heart disease death, nonfatal acute myocardial infarction and other clinical outcomes in the Multiple Risk Factor Intervention Trial. Multiple Risk Factor Intervention Trial Research Group. , 1986, The American journal of cardiology.

[23]  R. Gregg,et al.  Apolipoprotein E metabolism in normolipoproteinemic human subjects. , 1984, Journal of lipid research.

[24]  F. W. Robertson,et al.  Polymorphism at the Apoprotein‐E locus in relation to risk of coronary disease , 1984, Clinical genetics.

[25]  G. Assmann,et al.  Apolipoprotein E Polymorphism and Coronary Artery Disease , 1983, Arteriosclerosis.

[26]  R. Mahley,et al.  Lipoprotein receptors and cholesterol homeostasis. , 1983, Biochimica et biophysica acta.

[27]  R. Mahley,et al.  Human apolipoprotein E. The complete amino acid sequence. , 1982, The Journal of biological chemistry.

[28]  R. Mahley,et al.  Abnormal lipoprotein receptor-binding activity of the human E apoprotein due to cysteine-arginine interchange at a single site. , 1982, The Journal of biological chemistry.

[29]  R. Gregg,et al.  Type III hyperlipoproteinemia: defective metabolism of an abnormal apolipoprotein E. , 1981, Science.